Tin tức & Cập nhật
Xem bài viết Dược
Xem
Chỉ hiển thị Multimedia
Obefazimod hits targets in identical trials on active UC
31 Dec 2025
bởiAudrey Abella
Two phase III induction trials have demonstrated the efficacy and safety of obefazimod, an oral, first-in-class, small molecule, for the treatment of adults with moderate-to-severe ulcerative colitis (UC).
Obefazimod hits targets in identical trials on active UC
31 Dec 2025
Multidrug combos provide optimal glycaemic control in T2D patients
24 Dec 2025
bởiAudrey Abella
A real-world study from India shows that multiple drug combinations effectively controlled blood sugar levels in individuals with type 2 diabetes (T2D).